Swedish Orphan Biovitrum AB (publ) BIOVF
Set alert
46.00 USD +0.28 +0.62%
At close · Oct 30
46.00 Day range 46.00
34.88 52-week range 49.03
- YTD
- +30.50%
- 1 year
- +38.14%
- Open
- 46.00
- Prev close
- 45.72
- Mkt cap
- 16.01B
- Vol
- 102
- Avg vol
- 326
- EPS
- 2.02
- P/E
- 22.77
More statistics
- Low
- 46.00
- High
- 46.00
- Earnings
- Oct 27, 2026
2Y chart
Events in this range
- Jul 16, 2025Earnings: 0.24; estimate 0.177; surprise 35.59%
- Oct 20, 2025Earnings: 0.64; estimate 0.4925; surprise 29.95%
- Feb 5, 2026Earnings: 0.6; estimate 0.4567; surprise 31.38%
- Apr 28, 2026Earnings: 0.45; estimate 0.3821; surprise 17.77%
- Jul 16, 2026Earnings: 0.3288; estimate 0.38; surprise -13.47%
- Oct 27, 2026Earnings: —; estimate 0.63; surprise —%
Signals (48)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 21, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 19, 2026 | 2 weeks ago |
| SMA: Bearish | Sep 29, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 29, 2026 | 1 month ago |
| RSI: Oversold | Sep 3, 2026 | 2 months ago |
| MACD: Buy Signal | Sep 2, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 22, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 10, 2026 | 3 months ago |
| MACD: Sell Signal | May 19, 2026 | 5 months ago |
| MACD: Buy Signal | Apr 27, 2026 | 6 months ago |
| RSI: Overbought | Apr 27, 2026 | 6 months ago |
| MACD: Sell Signal | Mar 23, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 4, 2026 | 8 months ago |
| MACD: Sell Signal | Jan 28, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 7, 2026 | 10 months ago |
| MACD: Sell Signal | Nov 14, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 5, 2025 | 12 months ago |
| MACD: Sell Signal | Oct 23, 2025 | 1 year ago |
| RSI: Overbought | Oct 6, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 18, 2025 | 1 year ago |
Newest 20 of 48.
Next earnings
Oct 27, 2026
Expected Oct 27, 2026. Consensus EPS estimate 0.63.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Oct 27, 2026 | Sep 30, 2026 | 0.63 | — | — | — |
| Jul 16, 2026 | Jun 30, 2026 | 0.38 | 0.3288 | -0.05 | -13.47% |
| Apr 28, 2026 | Mar 31, 2026 | 0.3821 | 0.45 | +0.07 | +17.77% |
| Feb 5, 2026 | Dec 31, 2025 | 0.4567 | 0.60 | +0.14 | +31.38% |
| Oct 20, 2025 | Sep 30, 2025 | 0.4925 | 0.64 | +0.15 | +29.95% |
| Jul 16, 2025 | Jun 30, 2025 | 0.177 | 0.24 | +0.06 | +35.59% |
News
- Swedish Orphan Biovitrum (BIOVF) Tops Q3 Earnings and Revenue Estimates
- Earnings Preview: Swedish Orphan Biovitrum (BIOVF) Q3 Earnings Expected to Decline
- Swedish Orphan Biovitrum (OTCMKTS:BIOVF) Receives Consensus Recommendation of “Moderate Buy” from Analysts
- Swedish Orphan Biovitrum (OTCMKTS:BIOVF) Sees Large Decline in Short Interest
- Swedish Orphan Biovitrum (OTCMKTS:BIOVF) Short Interest Update
- Swedish Orphan Biovitrum AB (publ) (SWOBY) Q1 2026 Earnings Call Transcript
- Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)
- Swedish Orphan Biovitrum AB (publ) (SWOBY) Analyst/Investor Day Transcript
- Swedish Orphan Biovitrum AB (publ) (SWOBY) Q4 2025 Earnings Call Transcript
- Reviewing Swedish Orphan Biovitrum (OTCMKTS:BIOVF) & Astria Therapeutics (NASDAQ:ATXS)
Your note
Sign in to keep a note on BIOVF — it syncs with the Stock Master app.